Tekturna and Nasal congestion - a phase IV clinical study of FDA data

Summary:

Nasal congestion is reported as a side effect among people who take Tekturna (aliskiren hemifumarate), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Spiriva, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Nasal congestion when taking Tekturna. It is created by eHealthMe based on reports of 4,498 people who have side effects when taking Tekturna from the FDA, and is updated regularly.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

What is Nasal congestion?

Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels) is found to be associated with 1,753 drugs and 2,496 conditions by eHealthMe. Check the latest studies of Nasal congestion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

4,498 people reported to have side effects when taking Tekturna.
Among them, 30 people (0.67%) have Nasal congestion.

Among these 30 people:

How long have people been on Tekturna when they have Nasal congestion? *

What is the gender of people who have Nasal congestion when taking Tekturna? *

female: 60 %
male: 40 %

What is the age of people who have Nasal congestion when taking Tekturna? *

What are other drugs people take besides Tekturna? *

What are other side effects people have besides Nasal congestion? *

Cough: 7 people, 23.33%
Itching: 6 people, 20.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 16.67%
Pain In Extremity: 5 people, 16.67%
Fatigue (feeling of tiredness): 5 people, 16.67%
Gastrointestinal Infection (infection of stomach and intestine): 4 people, 13.33%
Sleep Disorder: 4 people, 13.33%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 13.33%
Dry Mouth: 4 people, 13.33%
Hypotension (abnormally low blood pressure): 4 people, 13.33%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 20.00%
Type 2 Diabetes: 2 people, 6.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.67%
Malignant Hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage): 1 person, 3.33%
Asthma: 1 person, 3.33%
Cardiac Disorder: 1 person, 3.33%
Colitis Microscopic (inflammation of colon with diarrhoea and abdominal cramps): 1 person, 3.33%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 3.33%
High Blood Cholesterol: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tekturna and have Nasal congestion?

- Check whether Nasal congestion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tekturna:

Tekturna (4,730 reports)

Nasal congestion treatments and more:

Nasal congestion (81,823 reports)

Browse all side effects of Tekturna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nasal congestion:

Nasal congestion (1,753 drugs)

Browse all the conditions that are associated with Nasal congestion:

Nasal congestion (2,496 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aliskiren hemifumarate (the active ingredients of Tekturna) and Tekturna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.